Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa

Archive ouverte

Shimakawa, Yusuke | Njie, Ramou | Ndow, Gibril | Vray, Muriel | Mbaye, Papa Saliou | Bonnard, Philippe | Sombié, Roger | Nana, Jean | Leroy, Vincent | Bottero, Julie | Ingiliz, Patrick | Post, Gerrit | Sanneh, Bakary | Baldeh, Ignatius | Suso, Penda | Ceesay, Amie | Jeng, Adam | Njai, Harr Freeya | Nayagam, Shevanthi | d'Alessandro, Umberto | Chemin, Isabelle | Mendy, Maimuna | Thursz, Mark | Lemoine, Maud

Edité par CCSD ; Elsevier -

International audience. To eliminate hepatitis B virus (HBV) infection, it is essential to scale up antiviral treatment through decentralized services. However, access to the conventional tools to assess treatment eligibility (liver biopsy/Fibroscan®/HBV DNA) is limited and not affordable in resource-limited countries. We developed and validated a simple score to easily identify patients in need of HBV treatment in Africa.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion